DDMC-p53 Gene Therapy with or without Cisplatin and Microwave Ablation [Expression of Concern]
OncoTargets and Therapy · 2026-08 · Volume 19 · 1-1
DOI: 10.2147/ott.s645911 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-08. Verfasst von Wolfgang Hohenforst-Schmidt und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hohenforst-Schmidt, W., Zarogoulidis, P. P., Stopek, J., Vogl, T., Hübner, F., Turner, J. F., Browning, R., Zarogoulidis, K., Drevelegas, A., Drevelegas, K., Darwiche, K., Freitag, L., & Rittger, H. (2026). DDMC-p53 Gene Therapy with or without Cisplatin and Microwave Ablation [Expression of Concern]. OncoTargets and Therapy, Volume 19, 1-1. https://doi.org/10.2147/ott.s645911
Vancouver
Hohenforst-Schmidt W, Zarogoulidis PP, Stopek J, Vogl T, Hübner F, Turner JF, et al. DDMC-p53 Gene Therapy with or without Cisplatin and Microwave Ablation [Expression of Concern]. OncoTargets and Therapy. 2026;Volume 19:1-1. doi:10.2147/ott.s645911
BibTeX
@article{HohenforstSchmidt2026,
author = {Hohenforst-Schmidt, Wolfgang and Zarogoulidis, Paul PZ and Stopek, Joshua and Vogl, Thomas and Hübner, Frank and Turner, J Francis and Browning, Robert and Zarogoulidis, Konstantinos and Drevelegas, Antonis and Drevelegas, Konstantinos and Darwiche, Kaid and Freitag, Lutz and Rittger, Harald},
title = {DDMC-p53 Gene Therapy with or without Cisplatin and Microwave Ablation [Expression of Concern]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--1},
doi = {10.2147/ott.s645911}
}
EUVIMED